Skip to main content
. Author manuscript; available in PMC: 2017 Jul 3.
Published in final edited form as: Transl Cancer Res. 2017 Feb;6(Suppl 1):S78–S82. doi: 10.21037/tcr.2017.02.12

Table.

ALK inhibitors, targets, mutational activity profiles, and toxicities

Drug Targets Sensitive ALK mutations Resistant ALK mutations Most common grade 1–2 side effects Most common grade 3–4 side effects References
Crizotinib ALK
MET
ROS1
L1198F 1151T ins
L1152R
C1156Y
F1174L
L1196M
L1198F
G1202R
S1206Y
G1269A
Visual changes
Orthostatic hypotension, Elevated creatinine, Peripheral edema
Nausea
Diarrhea
Fatigue
Constipation
[18][29]
Ceritinib ALK
IGF-R1
InsR
ROS1
L1196M G1269A I1171T S1206Y
L1152R F1174L V1180L
G1202R F1174C
C1156Y
.
Constipation Abdominal pain Decreased appetite Diarrhea
Vomiting
Dehydration
Elevated LFTs
Low Phosphorous
Elevated Lipase
Fatigue
[16][18]
Alectinib ALK
LTK
GAK
L1196M C1156Y F1174L
G1269A
S1206Y
L1152R
1151T-ins
G1202
V1180L
I1171T
Dysgeusia
Elevated AST
Elevated ALT
Elevated bilirubin Elevated creatinine
Rash
Constipation
Fatigue
Myalgia
Edema
Elevated CPK
Nausea
Photosensitivity
Neutropenia
Elevated creatinine Elevated CPK
[20]
Brigatinib ALK
ROS1
EGFR (including T790m)*
G1202R
L1196M
C1156Y
G1202R
G1269A
S1206Y
1151T-ins
F1174C
I1171T
D1203N
E1210k
F1245C
L1198F Nausea
Fatigue
Headache, Diarrhea
Vomiting
Edema
Elevated ALT
Dyspnea
Pneumonia
Pulmonary embolism
Elevated lipase
Hypertension
Elevated amylase
Fatigue
Hyponatraemia Hypophosphatemia
[21]
Entrectinib NTRK, ROS1, ALK L1196M
C1156Y
Paraesthesia
Asthenia
Nausea
Vomiting
Myalgia
Arthralgia
Dysgeusia
Diarrhea
Asthenia
Muscle weakness
Cognitive impairment
[30]
Lorlatinib
ALK
ROS1
L1196M
G1202R
G1269A
L1198F Hypercholesterolemia
Peripheral edema Peripheral neuropathy
Hypercholesterolemia [31]
*

Preclinical evidence of activity against activating and resistance EGFR mutations but minimal clinical efficacy.

InsR: Insulin receptor.

IGF-R1: Insulin like growth factor.

MET: Proto-oncogene protein c-MET

ALK: Anaplastic lymphoma kinase

EGFR: Epidermal growth factor receptor

ROS1: ROS Proto-Oncogene 1

LTK: Leukocyte Receptor Tyrosine Kinase

GAK: Cyclin G-associated kinase

ALT: Alanine transaminase

AST: Aspartate transaminase

LFTs: Liver function tests

CPK: Creatine phosphokinase

NTRK1: Neutrotrophic tyrosine kinase 1